For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Amicus Therapeutics Inc (NASDAQ: FOLD) closed at $9.76 in the last session, down -1.01% from day before closing price of $9.86. In other words, the price has decreased by -$1.01 from its previous closing price. On the day, 1.73 million shares were traded. FOLD stock price reached its highest trading level at $9.88 during the session, while it also had its lowest trading level at $9.72.
Ratios:
We take a closer look at FOLD’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.42 and its Current Ratio is at 3.15. In the meantime, Its Debt-to-Equity ratio is 2.49 whereas as Long-Term Debt/Eq ratio is at 2.44.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on September 06, 2024, initiated with a Buy rating and assigned the stock a target price of $18.
On May 30, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $18.
Guggenheim Upgraded its Neutral to Buy on May 14, 2024, while the target price for the stock was maintained at $13.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 02 ’24 when Campbell Bradley L sold 7,500 shares for $10.02 per share. The transaction valued at 75,124 led to the insider holds 886,654 shares of the business.
BRADLEY CAMPBELL bought 7,500 shares of FOLD for $74,850 on Dec 02 ’24. On Nov 06 ’24, another insider, Campbell Bradley L, who serves as the President and CEO of the company, sold 7,901 shares for $12.50 each. As a result, the insider received 98,800 and left with 886,654 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FOLD now has a Market Capitalization of 2946222080 and an Enterprise Value of 3111245312. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.91 while its Price-to-Book (P/B) ratio in mrq is 16.30. Its current Enterprise Value per Revenue stands at 6.302 whereas that against EBITDA is 134.75.
Stock Price History:
Over the past 52 weeks, FOLD has reached a high of $14.57, while it has fallen to a 52-week low of $9.02. The 50-Day Moving Average of the stock is -8.14%, while the 200-Day Moving Average is calculated to be -9.82%.
Shares Statistics:
According to the various share statistics, FOLD traded on average about 2.34M shares per day over the past 3-months and 1738090 shares per day over the past 10 days. A total of 298.69M shares are outstanding, with a floating share count of 291.20M. Insiders hold about 2.55% of the company’s shares, while institutions hold 102.66% stake in the company. Shares short for FOLD as of 1731628800 were 20997095 with a Short Ratio of 8.98, compared to 1728950400 on 21943855. Therefore, it implies a Short% of Shares Outstanding of 20997095 and a Short% of Float of 7.0700005.
